HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.

Abstract
Current diagnostic tools cannot predict clinical failure and androgen-independent disease progression for patients with prostate cancer (PC). The survival signaling pathways of prostate cells play a central role in the progression of tumors to a neuroendocrine (NE) phenotype. NE cells demonstrate attributes that suggest that they are an integral part of the signaling cascade leading to castration-resistant PC. In this study, making use of in vitro neuroendocrine differentiation (NED) of human LNCaP and mouse TRAMP-C2 cells after androgen withdrawal, and of the transgenic adenocarcinoma of mouse prostate (TRAMP) model, we characterized a sequence of molecular events leading to NED and identified a number of markers that could be detectable by routine analyses not only in castration resistant PC but also in hormone naïve PC at the time of initial diagnosis. We found that NED associates with AKT activation that in turn regulates heterogeneous nuclear ribonucleoprotein K (hnRNP K), androgen receptor (AR) and β-catenin levels. Addition of molecules targeting membrane-bound receptors and protein kinases blocks NE differentiation in LNCaP and TRAMP-C2 cells. The extent of AKT phosphorylation and hnRNP K, AR and β-catenin levels may have a potential value as prognostic indicators discriminating between androgen-responsive and unresponsive cells and could be used as molecular targets to monitor the anti-tumor action of new therapeutic protocols based on antireceptor agents and/or neuroendocrine hormone antagonists.
AuthorsMonica Ciarlo, Roberto Benelli, Ottavia Barbieri, Simona Minghelli, Paola Barboro, Cecilia Balbi, Nicoletta Ferrari
JournalInternational journal of cancer (Int J Cancer) Vol. 131 Issue 3 Pg. 582-90 (Aug 01 2012) ISSN: 1097-0215 [Electronic] United States
PMID22015967 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 UICC.
Chemical References
  • AR protein, human
  • Androgens
  • Heterogeneous-Nuclear Ribonucleoprotein K
  • Receptors, Androgen
  • beta Catenin
  • Proto-Oncogene Proteins c-akt
Topics
  • Adenocarcinoma (metabolism, pathology)
  • Androgens (metabolism)
  • Animals
  • Cell Differentiation
  • Cell Line, Tumor
  • Heterogeneous-Nuclear Ribonucleoprotein K (metabolism)
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neuroendocrine Cells (metabolism, pathology)
  • Phosphorylation
  • Prostatic Neoplasms (metabolism, pathology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Receptors, Androgen (metabolism)
  • Signal Transduction
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: